FUNCTIONAL RESIDUAL CAPACITY INCREASED

FUNCTIONAL RESIDUAL CAPACITY INCREASED was reported 39 times

FUNCTIONAL RESIDUAL CAPACITY INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DICLOFENAC SODIUM AND MISOPROSTOL 8 0.0012
1 CICLESONIDE 8 0.0006
2 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 27 0.0004
3 DESOXIMETASONE 8 0.0004
4 VORICONAZOLE 9 0.0003
5 TIOTROPIUM BROMIDE INHALATION SPRAY 3 0.0003
6 LORATADINE AND PSEUDOEPHEDRINE SULFATE 2 0.0003
7 OMALIZUMAB 18 0.0002
8 FLUOXETINE HCL 1 0.0002
9 GLYCOPYRROLATE 1 0.0002
10 TIOTROPIUM BROMIDE 24 0.0002
11 LEVOFLOXACIN 10 0.0002
12 MONTELUKAST SODIUM 19 0.0002
13 CETIIRIZINE 5 0.0001
14 FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE 4 0.0001
15 MEPOLIZUMAB 5 0.0001
16 ALBUTEROL SULFATE 21 0.0001
17 ROSUVASTATIN CALCIUM 2 0.0001
18 CETIRIZINE HYDROCHLORIDE TABLETS 2 0.0001
19 ESCITALOPRAM 8 0.0001
20 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 5 0.0001
21 MOMETASONE FUROATE 2 0.0000
22 CETIRIZINE HYDROCHLORIDE 7 0.0000
23 HYDROCHLOROTHIAZIDE 6 0.0000
24 RANIBIZUMAB 1 0.0000
25 RANITIDINE HYDROCHLORIDE 2 0.0000
26 PREDNISONE 18 0.0000
27 ROSUVASTATIN 3 0.0000
28 ERGOCALCIFEROL 1 0.0000
29 FLUOXETINE HYDROCHLORIDE 4 0.0000
30 HYDROCORTISONE 2 0.0000
31 PANTOPRAZOLE 5 0.0000
32 AMLODIPINE 4 0.0000
33 LEVONORGESTREL 1 0.0000
34 ASPIRIN 1 0.0000